Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc.
01/13/2026 | Press release | Distributed by Public on 01/13/2026 15:31
Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 7, 2026, Surendra Ajjarapu, a Director of Aspire Biopharma Holdings, Inc. (the "Company"), notified the Board of Directors of his intention to step down from the role of Director, effective immediately. Mr. Ajjarapu's decision to resign is not due to any disagreement with the Company, the Board of Directors, or any member of the Company's management.
| Exhibit No. | Description | |
| 104 | Cover Page Interactive Data File (embedded with the Inline XBRL document) |
Aspire Biopharma Holdings Inc. published this content on January 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 13, 2026 at 21:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]